524 related articles for article (PubMed ID: 30240060)
1. Astrocytes, the rising stars of the glioblastoma microenvironment.
Brandao M; Simon T; Critchley G; Giamas G
Glia; 2019 May; 67(5):779-790. PubMed ID: 30240060
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
3. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
Civita P; M Leite D; Pilkington GJ
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
[TBL] [Abstract][Full Text] [Related]
4. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma.
Yang N; Yan T; Zhu H; Liang X; Leiss L; Sakariassen PØ; Skaftnesmo KO; Huang B; Costea DE; Enger PØ; Li X; Wang J
J Transl Med; 2014 Oct; 12():278. PubMed ID: 25280402
[TBL] [Abstract][Full Text] [Related]
5. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics.
Leite DM; Zvar Baskovic B; Civita P; Neto C; Gumbleton M; Pilkington GJ
FASEB J; 2020 Jan; 34(1):1710-1727. PubMed ID: 31914660
[TBL] [Abstract][Full Text] [Related]
6. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions.
Zhang X; Ding K; Wang J; Li X; Zhao P
Biomed Pharmacother; 2019 Jan; 109():39-46. PubMed ID: 30391707
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
9. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
[TBL] [Abstract][Full Text] [Related]
10. Flavagline synthetic derivative induces senescence in glioblastoma cancer cells without being toxic to healthy astrocytes.
Harmouch E; Seitlinger J; Chaddad H; Ubeaud-Sequier G; Barths J; Saidu S; Désaubry L; Grandemange S; Massfelder T; Fuhrmann G; Fioretti F; Dontenwill M; Benkirane-Jessel N; Idoux-Gillet Y
Sci Rep; 2020 Aug; 10(1):13750. PubMed ID: 32792639
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes enhance glioblastoma growth.
Mega A; Hartmark Nilsen M; Leiss LW; Tobin NP; Miletic H; Sleire L; Strell C; Nelander S; Krona C; Hägerstrand D; Enger PØ; Nistér M; Östman A
Glia; 2020 Feb; 68(2):316-327. PubMed ID: 31509308
[TBL] [Abstract][Full Text] [Related]
12. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.
Lindemann C; Marschall V; Weigert A; Klingebiel T; Fulda S
Neoplasia; 2015 Jun; 17(6):481-9. PubMed ID: 26152356
[TBL] [Abstract][Full Text] [Related]
13. Perivascular Stromal Cells Instruct Glioblastoma Invasion, Proliferation, and Therapeutic Response within an Engineered Brain Perivascular Niche Model.
Ngo MT; Sarkaria JN; Harley BAC
Adv Sci (Weinh); 2022 Nov; 9(31):e2201888. PubMed ID: 36109186
[TBL] [Abstract][Full Text] [Related]
14. Breaking through the glioblastoma micro-environment via extracellular vesicles.
Simon T; Jackson E; Giamas G
Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
16. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
[TBL] [Abstract][Full Text] [Related]
17. Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.
Fanelli GN; Grassini D; Ortenzi V; Pasqualetti F; Montemurro N; Perrini P; Naccarato AG; Scatena C
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804731
[TBL] [Abstract][Full Text] [Related]
18. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
Jiang X; Zhou T; Wang Z; Qi B; Xia H
ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.
Persano L; Rampazzo E; Basso G; Viola G
Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412
[TBL] [Abstract][Full Text] [Related]
20. Understanding current experimental models of glioblastoma-brain microenvironment interactions.
Yadav N; Purow BW
J Neurooncol; 2024 Jan; 166(2):213-229. PubMed ID: 38180686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]